Nucleotide analogues containing a pyrrolidine, piperidine or piperazine ring: Synthesis and evaluation of inhibition of plasmodial and human 6-oxopurine phosphoribosyltransferases and in vitro antimalarial activity.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
05 Jul 2021
Historique:
received: 07 12 2020
revised: 24 03 2021
accepted: 25 03 2021
pubmed: 23 4 2021
medline: 12 8 2021
entrez: 22 4 2021
Statut: ppublish

Résumé

Parasites of the Plasmodium genus are unable to produce purine nucleotides de novo and depend completely on the salvage pathway. This fact makes plasmodial hypoxanthine-guanine-(xanthine) phosphoribosyltransferase [HG(X)PRT] a valuable target for development of antimalarial agents. A series of nucleotide analogues was designed, synthesized and evaluated as potential inhibitors of Plasmodium falciparum HGXPRT, P. vivax HGPRT and human HGPRT. These novel nucleoside phosphonates have a pyrrolidine, piperidine or piperazine ring incorporated into the linker connecting the purine base to a phosphonate group(s) and exhibited a broad range of K

Identifiants

pubmed: 33887682
pii: S0223-5234(21)00265-8
doi: 10.1016/j.ejmech.2021.113416
pii:
doi:

Substances chimiques

Antimalarials 0
Enzyme Inhibitors 0
Nucleotides 0
Piperidines 0
Prodrugs 0
Protozoan Proteins 0
Pyrrolidines 0
Piperazine 1RTM4PAL0V
Pentosyltransferases EC 2.4.2.-
hypoxanthine-guanine-xanthine phosphoribosyltransferase EC 2.4.2.-
pyrrolidine LJU5627FYV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113416

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jan Frydrych (J)

The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, CZ-16610 Prague 6, Czech Republic.

Dianne T Keough (DT)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, 4068, Australia.

Marina Chavchich (M)

Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Enoggera, Brisbane, Queensland 4051, Australia.

Jye Travis (J)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, 4068, Australia; Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Enoggera, Brisbane, Queensland 4051, Australia.

Martin Dračínský (M)

The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, CZ-16610 Prague 6, Czech Republic.

Michael D Edstein (MD)

Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Enoggera, Brisbane, Queensland 4051, Australia.

Luke W Guddat (LW)

School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, 4068, Australia.

Dana Hocková (D)

The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, CZ-16610 Prague 6, Czech Republic.

Zlatko Janeba (Z)

The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, CZ-16610 Prague 6, Czech Republic. Electronic address: janeba@uochb.cas.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH